T
GILD icon

TOBAM’s Gilead Sciences GILD Stock Holding History

TOBAM’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-9,275
Closed -$857K – 283
2024
Q4 		$857K Sell
9,275
-3,687
-28% -$332K 0.26% 78
2024
Q3 		$1.09M Buy
12,962
+730
+6% +$55.7K 0.2% 90
2024
Q2 		$839K Sell
12,232
-14,132
-54% -$943K 0.13% 99
2024
Q1 		$1.93M Hold
26,364
– – 0.17% 79
2023
Q4 		$2.14M Sell
26,364
-4,130
-14% -$321K 0.19% 70
2023
Q3 		$2.29M Sell
30,494
-2,078
-6% -$160K 0.18% 70
2023
Q2 		$2.51M Sell
32,572
-37,695
-54% -$3.01M 0.19% 75
2023
Q1 		$5.83M Sell
70,267
-83,576
-54% -$6.92M 0.38% 52
2022
Q4 		$13.2M Sell
153,843
-59,844
-28% -$4.74M 0.87% 43
2022
Q3 		$13.2M Sell
213,687
-85,283
-29% -$5.38M 0.92% 40
2022
Q2 		$18.5M Sell
298,970
-504,021
-63% -$31.2M 1.16% 32
2022
Q1 		$47.7M Sell
802,991
-100,590
-11% -$6.43M 2.4% 4
2021
Q4 		$65.6M Sell
903,581
-63,697
-7% -$4.39M 2.95% 2
2021
Q3 		$67.6M Sell
967,278
-82,867
-8% -$5.82M 2.87% 1
2021
Q2 		$72.3M Sell
1,050,145
-27,705
-3% -$1.85M 2.89% 1
2021
Q1 		$69.7M Sell
1,077,850
-8,223
-0.8% -$530K 2.96% 1
2020
Q4 		$63.3M Buy
1,086,073
+154,918
+17% +$9.35M 2.82% 2
2020
Q3 		$58.8M Buy
931,155
+519,455
+126% +$36M 2.94% 3
2020
Q2 		$31.7M Buy
+411,700
New +$31.6M 2.04% 18
2018
Q1 		– Sell
-8,108
Closed -$581K – 171
2017
Q4 		$581K Sell
8,108
-321
-4% -$24.4K 0.03% 146
2017
Q3 		$683K Buy
+8,429
New +$645K 0.03% 136
2015
Q4 		– Sell
-46,740
Closed -$4.59M – 122
2015
Q3 		$4.59M Sell
46,740
-3,413
-7% -$379K 0.18% 78
2015
Q2 		$5.87M Sell
50,153
-935
-2% -$102K 0.21% 79
2015
Q1 		$5.01M Buy
51,088
+48,767
+2,101% +$4.95M 0.15% 84
2014
Q4 		$219K Buy
+2,321
New +$240K 0.01% 131

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

TOBAM's GILD Position: Q1 2025 in Review

TOBAM sold out of Gilead Sciences (GILD) in Q1 2025, closing a stake of 9,275 shares — an estimated $857K sold.

TOBAM first reported a position in GILD in Q4 2014 and held it in 25 quarters. The position peaked at $72.3M in Q2 2021. 2,019 funds tracked by Wall St. Rank hold GILD as of Q1 2025.

  • TOBAM reported no remaining Gilead Sciences position as of Q1 2025 after selling out during the quarter.
  • TOBAM sold 9,275 Gilead Sciences shares in Q1 2025, an estimated $857K.
  • TOBAM first reported a position in Gilead Sciences in Q4 2014 and held it in 25 quarters.
  • TOBAM's Gilead Sciences position peaked at $72.3M in Q2 2021.
  • 2,019 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2025.

Based on TOBAM's 13F filing for Q1 2025, filed 16 Apr 2025.